Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background Interventions aimed to increase adherence to drug treatment usually are not tailored to the needs of individual patients. A modular pharmacy intervention, named ‘Support for Diabetes’, was developed to improve adherence to type 2 diabetes treatment. Objective To evaluate the implementation of a new care intervention by using focus groups including pharmacy teams, and assess patient satisfaction. Setting Community pharmacies in The Netherlands Method The intervention comprises a structured patient interview, an intervention guide and modular interventions tailored to the underlying cause of non-adherence. Feasibility was studied in non-adherent type 2 diabetes mellitus patients, and evaluated by means of focus group interviews with pharmacists and pharmacy technicians. Topics included practicability of the patient selection procedure, patient interviews, materials developed for the intervention and general practitioner (GP) co-operation. Patients’ experiences (n = 36) were assessed by means of a questionnaire. Main outcome measure Feasibility of the intervention and patients’ satisfaction. Results Pharmacists and pharmacy technicians considered the intervention feasible and appreciated its pro-active approach. Involvement of pharmacy technicians proved a stimulating factor. Poor co-operation with GPs and lack of time as well as financial compensation were interfering factors. Patients appreciated the intervention and reported to follow the advice of pharmacists. Conclusion The ‘Support for Diabetes’ intervention is feasible to implement in pharmacy practice. Poor co-operation between pharmacists and GPs and lack of re-imbursement are obstructions for implementation on a wider scale. These issues should receive attention of pharmacists, policymakers and researchers.
- Baan CA, Poos MJJC. Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan. RIVM 2005.
- Herings RMC, et al. Chronische Farmacotherapie Voorgezet—Een onderzoek naar de omvang, determinanten en mogelijke economische consequenties van het vroegtijdig afbreken van chronische farmacotherapie, PHARMO Instituut 2002.
- Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence (Review). Cochrane Database Syst Rev. 2008; (2):CD000011.
- Ho, PM, Rumsfeld, JS, Masoudi, FA, McClure, DL, Plomondon, ME, Steiner, JF, Magid, DJ (2006) Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 17: pp. 1836-1841 CrossRef
- Sabaté, E (2003) Adherence to long-term therapies. Evidence for action. World Health Organization, Geneva
- Lee, WC, Balu, S, Cobden, D (2006) Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 19: pp. 31-41
- Wroe, AL (2002) Intentional and unintentional nonadherence: a study of decision-making. J Behav Med 25: pp. 355-372 CrossRef
- Lehane, E, McCarthy, G (2007) Intentional and unintentional non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud 44: pp. 1468-1477 CrossRef
- Lowry, KP, Dudley, TK, Oddone, EZ, Bosworth, HB (2005) Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 39: pp. 1198-1203 CrossRef
- Brown, KK, Rehmus, WE, Kimball, AB (2006) Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 55: pp. 607-613 CrossRef
- Hugtenburg, JG, Blom, ATG, Kisoensingh, SU (2006) Initial phase of chronic medication use; patients’ reasons for discontinuation. Br J Clin Pharmacol 61: pp. 352-354 CrossRef
- Vermeire E, Wens J, Van Royen P, et al. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005; (2):1–37.
- Sluijs, EM, Dulmen, S, Dijk, L (2006) Patient adherence to medical treatment: a meta review. NIVEL, Utrecht
- Horne, R, Weinman, J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47: pp. 555-567 CrossRef
- Wong, LP (2008) Focus group discussion: a tool for health and medical research. Singapore Med J 49: pp. 256-260
- Pope, C, Ziebland, S, Mays, N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320: pp. 114-116 CrossRef
- Herborg, H, Haugbølle, LS, Sørensen, L (2008) Developing a generic, individualised adherence programme for chronic medication users. Pharm Pract. 6: pp. 148-157
- DiMatteo, MR, Haskard-Zolnierek, KB, Martin, LM (2012) Improving patient adherence: a three-factor model to guide practice. Health Psychol Rev. 6: pp. 74-91 CrossRef
- Tinelli, M, Ryan, M (2009) Bond C Patients’ preferences for an increased pharmacist role in the management of drug therapy. Int J Pharm Pract. 17: pp. 275-282 CrossRef
- Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review). Cochrane Lib. 2001; (2):2003.
- Krska, J, Cromarty, JA, Arris, F (2001) Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 30: pp. 205-211 CrossRef
- Bernsten, C, Bjorkman, I, Caramona, M (2001) Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 18: pp. 63-77 CrossRef
- Sellors, J, Kaczorowski, J, Sellors, C (2003) A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 169: pp. 17-22
- Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy
International Journal of Clinical Pharmacy
Volume 35, Issue 6 , pp 1113-1119
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Community pharmacists
- Diabetes mellitus type-2
- Patients’ experience
- Pharmaceutical care
- Tailored intervention
- The Netherlands
- Industry Sectors
- Author Affiliations
- 1. Department of General Practice, VU University Medical Center, Amsterdam, The Netherlands
- 2. EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands
- 3. NIVEL, Utrecht, The Netherlands
- 4. Kring Apotheken Nederland, Utrecht, The Netherlands
- 5. Royal Dutch Association for Pharmacy, Den Haag, The Netherlands
- 6. Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands